{"entity":{"type":"insider","cik":"0001581950","url":"/insider/0001581950","json_url":"/insider/0001581950.json","name":"Cantley Lewis Clayton Jr.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":142,"n_filings":31,"first":"2015-03-30","last":"2017-12-08","span_basis":"filed_date"},"name_variants":[{"name":"Cantley Lewis Clayton Jr.","source":"filing","n_filings":31,"first_seen":"2015-03-30","last_seen":"2017-12-08"}],"transactions":[{"id":4168173,"accession":"0001209191-17-064704","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-17-064704","line_url":"/filing/0001209191-17-064704","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1838.0,"shares_display":"1,838","price_per_share":60.20869423286181,"price_display":"60.21","price_state":"stated","total_value":110663.58,"total_display":"110,663.58","total_whole":"110,664","shares_owned_after":79515.0,"shares_owned_after_display":"79,515","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-07","filed_date":"2017-12-08","scope":"insider","n_lines":4},{"id":4168161,"accession":"0001209191-17-064704","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-17-064704","line_url":"/filing/0001209191-17-064704","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":58.596615,"price_display":"58.60","price_state":"stated","total_value":117193.23,"total_display":"117,193.23","total_whole":"117,193","shares_owned_after":80851.0,"shares_owned_after_display":"80,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-06","filed_date":"2017-12-08","scope":"insider","n_lines":6},{"id":4872498,"accession":"0001209191-17-060967","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-17-060967","line_url":"/filing/0001209191-17-060967","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":59.6999,"price_display":"59.70","price_state":"stated","total_value":119399.8,"total_display":"119,399.80","total_whole":"119,400","shares_owned_after":81743.0,"shares_owned_after_display":"81,743","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-14","filed_date":"2017-11-15","scope":"insider","n_lines":4},{"id":4872490,"accession":"0001209191-17-060967","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-060967","line_url":"/filing/0001209191-17-060967","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":62.07,"price_display":"62.07","price_state":"stated","total_value":124140.0,"total_display":"124,140.00","total_whole":"124,140","shares_owned_after":82434.0,"shares_owned_after_display":"82,434","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-13","filed_date":"2017-11-15","scope":"insider","n_lines":2},{"id":4661452,"accession":"0001209191-17-057318","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-057318","line_url":"/filing/0001209191-17-057318","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":71.1,"price_display":"71.10","price_state":"stated","total_value":142200.0,"total_display":"142,200.00","total_whole":"142,200","shares_owned_after":83434.0,"shares_owned_after_display":"83,434","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-17","filed_date":"2017-10-18","scope":"insider","n_lines":2},{"id":4661446,"accession":"0001209191-17-057318","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-057318","line_url":"/filing/0001209191-17-057318","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":71.09,"price_display":"71.09","price_state":"stated","total_value":142180.0,"total_display":"142,180.00","total_whole":"142,180","shares_owned_after":84434.0,"shares_owned_after_display":"84,434","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-16","filed_date":"2017-10-18","scope":"insider","n_lines":2},{"id":4268393,"accession":"0001209191-17-053010","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-053010","line_url":"/filing/0001209191-17-053010","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":65.71,"price_display":"65.71","price_state":"stated","total_value":131420.0,"total_display":"131,420.00","total_whole":"131,420","shares_owned_after":85434.0,"shares_owned_after_display":"85,434","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-14","filed_date":"2017-09-15","scope":"insider","n_lines":2},{"id":4268386,"accession":"0001209191-17-053010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-053010","line_url":"/filing/0001209191-17-053010","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":65.47,"price_display":"65.47","price_state":"stated","total_value":130940.0,"total_display":"130,940.00","total_whole":"130,940","shares_owned_after":86434.0,"shares_owned_after_display":"86,434","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-13","filed_date":"2017-09-15","scope":"insider","n_lines":2},{"id":5281911,"accession":"0001209191-17-050096","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-17-050096","line_url":"/filing/0001209191-17-050096","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":57.08,"price_display":"57.08","price_state":"stated","total_value":114160.0,"total_display":"114,160.00","total_whole":"114,160","shares_owned_after":87934.0,"shares_owned_after_display":"87,934","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-08-23","filed_date":"2017-08-24","scope":"insider","n_lines":4},{"id":5281897,"accession":"0001209191-17-050096","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-050096","line_url":"/filing/0001209191-17-050096","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":56.62,"price_display":"56.62","price_state":"stated","total_value":113240.0,"total_display":"113,240.00","total_whole":"113,240","shares_owned_after":88934.0,"shares_owned_after_display":"88,934","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-08-22","filed_date":"2017-08-24","scope":"insider","n_lines":4},{"id":4197383,"accession":"0001209191-17-045921","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-17-045921","line_url":"/filing/0001209191-17-045921","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":57.125,"price_display":"57.12","price_state":"stated","total_value":114250.0,"total_display":"114,250.00","total_whole":"114,250","shares_owned_after":85237.0,"shares_owned_after_display":"85,237","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-07-20","filed_date":"2017-07-21","scope":"insider","n_lines":4},{"id":4197376,"accession":"0001209191-17-045921","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-045921","line_url":"/filing/0001209191-17-045921","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":56.144285714285715,"price_display":"56.14","price_state":"stated","total_value":393010.0,"total_display":"393,010.00","total_whole":"393,010","shares_owned_after":86737.0,"shares_owned_after_display":"86,737","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-07-19","filed_date":"2017-07-21","scope":"insider","n_lines":4},{"id":5036152,"accession":"0001209191-17-040187","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-040187","line_url":"/filing/0001209191-17-040187","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":51.09,"price_display":"51.09","price_state":"stated","total_value":51090.0,"total_display":"51,090.00","total_whole":"51,090","shares_owned_after":89737.0,"shares_owned_after_display":"89,737","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-14","filed_date":"2017-06-15","scope":"insider","n_lines":2},{"id":5036138,"accession":"0001209191-17-040187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-040187","line_url":"/filing/0001209191-17-040187","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":50.64,"price_display":"50.64","price_state":"stated","total_value":50640.0,"total_display":"50,640.00","total_whole":"50,640","shares_owned_after":90237.0,"shares_owned_after_display":"90,237","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-13","filed_date":"2017-06-15","scope":"insider","n_lines":2},{"id":5119233,"accession":"0001209191-17-035585","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-035585","line_url":"/filing/0001209191-17-035585","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1018.0,"shares_display":"1,018","price_per_share":46.92,"price_display":"46.92","price_state":"stated","total_value":47764.56,"total_display":"47,764.56","total_whole":"47,765","shares_owned_after":90737.0,"shares_owned_after_display":"90,737","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-25","filed_date":"2017-05-25","scope":"insider","n_lines":2},{"id":5119221,"accession":"0001209191-17-035585","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-035585","line_url":"/filing/0001209191-17-035585","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1018.0,"shares_display":"1,018","price_per_share":47.27,"price_display":"47.27","price_state":"stated","total_value":48120.86,"total_display":"48,120.86","total_whole":"48,121","shares_owned_after":91246.0,"shares_owned_after_display":"91,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-24","filed_date":"2017-05-25","scope":"insider","n_lines":2},{"id":4196581,"accession":"0001209191-17-027509","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-17-027509","line_url":"/filing/0001209191-17-027509","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001581950","owner_name":"Cantley Lewis Clayton Jr.","owner_display_name":"Cantley Lewis Clayton Jr.","owner_url":"/insider/0001581950","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1018.0,"shares_display":"1,018","price_per_share":50.92,"price_display":"50.92","price_state":"stated","total_value":51836.56,"total_display":"51,836.56","total_whole":"51,837","shares_owned_after":91755.0,"shares_owned_after_display":"91,755","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-18","filed_date":"2017-04-19","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2017-04-18|4196578","ledger_fault":false,"count":{"value":142,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":142,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":142},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS INC","url":"/issuer/0001439222","role":"Director","n_filings":31,"first_seen":"2015-03-30","last_seen":"2017-12-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001581950","retrieved_at":"2026-08-25T03:03:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}